Otrivin nasal spray 0.1% with menthol and eucalyptol 10ml №1

Name:
Otrivin nasal spray dozir. 0.1% with menthol and euc. in fl. 10ml in pack. №1_20564
Description:
White opalescent liquid with a smell of menthol and eucalyptus. The main active ingredient Xylometazoline Release form 10 ml in a bottle made of high-density polyethylene, equipped with a pump dispenser with a tip and a protective cap made of polyethylene. The bottle, along with instructions for use, is placed in a cardboard box. Dosage 10 ml Special instructions Do not exceed the recommended doses and duration of the drug. Influence on the work with mechanisms and ability to drive vehicles: Xylometazoline, in dosages exceeding the recommended ones, may affect the work with mechanisms and the ability to drive vehicles. Pharmacological action Pharmacological action occurs within a few minutes and lasts for several hours. Pharmacotherapeutic group: alpha-adrenomimetic. ATX code: R01AA07. Pharmacological properties: Xylometazoline belongs to the group of local vasoconstrictors (decongestants) with α-adrenergic action, which is manifested by: narrowing of the blood vessels of the mucosa and leads to the elimination of edema and hyperemia of the nasal mucosa and nasopharynx facilitates nasal breathing in rhinitis, menthol and eucalyptol contained in the preparation have a cooling effect on the nasal mucosa at therapeutic concentrations does not irritate the mucous membrane, does not cause hyperemia. Pharmacokinetics When applied topically, it is practically not absorbed, plasma concentrations are so low that they cannot be determined by modern analytical methods. Indications for use acute respiratory diseases with symptoms of rhinitis (runny nose) acute allergic rhinitis pollinosis sinusitis stachitis otitis media (to reduce swelling of the nasopharyngeal mucosa). preparation of the patient for diagnostic manipulations in the nasal passages. For adults and children over 6 years old: 1 injection in each nasal passage (can be repeated if necessary); 3-4 injections per day are usually sufficient. Duration of application – no more than 10 days in a row. Interaction with other drugs Incompatible with MAO inhibitors and tricyclic antidepressants. Contraindications Hypersensitivity to the components of the drug, arterial hypertension, tachycardia, severe atherosclerosis, glaucoma, atrophic rhinitis, hyperthyroidism, surgical interventions on the meninges (and history). Children’s age – up to 6 years. With caution – diabetes. Composition 1 ml solution for intranasal use contains: Active ingredient: xylometazoline hydrochloride 1 mg. Excipients: Sodium dihydrophosphate dihydrate, disodium phosphate dodecahydrate, sodium chloride, benzalkonium chloride, sorbitol, disodium edetate, levomenthol (menthol), cineole (eucalyptol), Cremophor RH 40, purified water. Overdose It is manifested by an increase in symptoms of side effects. Treatment is symptomatic. Side effect With frequent and / or prolonged use – irritation and / or dryness of the mucous membrane of the nasopharynx, burning, tingling, sneezing, hypersecretion of mucus. Rarely – swelling of the nasal mucosa, tachycardia, increased blood pressure, headache, dizziness, vomiting, insomnia, blurred vision. Storage conditions At a temperature not exceeding 25 ° C, out of the reach of children. Buy Otrivin nasal spray 0.1% with menthol and eucalyptol 10ml №1 Price for Otrivin nasal spray 0.1% with menthol and eucalyptol 10ml №1